Patents Assigned to Suregene, LLC
  • GENETIC MARKERS OF ANTIPSYCHOTIC RESPONSE
    Publication number: 20160122821
    Abstract: Provided herein are genetic markers for predicting response to antipsychotic treatment. Identification of the disclosed SNPs can be used to predict response to antipsychotic drugs in patients suffering from schizophrenia.
    Type: Application
    Filed: June 10, 2014
    Publication date: May 5, 2016
    Applicant: SUREGENE, LLC
    Inventors: Qian LIU, Mark D. BRENNAN
  • GENETIC MARKERS OF MENTAL ILLNESS
    Publication number: 20140288054
    Abstract: This invention relates to genetic markers of mental illness, e.g., schizophrenia (SZ), and methods of use thereof.
    Type: Application
    Filed: October 29, 2013
    Publication date: September 25, 2014
    Applicant: SureGene, LLC
    Inventors: Mark David Brennan, Timothy Lynn Ramsey
  • Genetic markers of mental illness
    Patent number: 8586308
    Abstract: This invention relates to genetic markers of mental illness, e.g., schizophrenia (SZ), and methods of use thereof.
    Type: Grant
    Filed: January 16, 2009
    Date of Patent: November 19, 2013
    Assignee: SureGene, LLC
    Inventors: Mark David Brennan, Timothy Lynn Ramsey
  • Methods and Compositions for the Treatment of Psychotic Disorders Through the Identification of the Olanzapine Poor Response Predictor Genetic Signature
    Publication number: 20130090329
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a OPRP genetic signature are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the genetic signature.
    Type: Application
    Filed: October 7, 2011
    Publication date: April 11, 2013
    Applicant: SUREGENE, LLC
    Inventors: Timothy L. Ramsey, Bharat Mehrotra, Mark D. Brennan
  • Genetic Markers for Assessing Risk of Developing Bipolar Disorder
    Publication number: 20120129171
    Abstract: This document provides methods and materials related to genetic markers of Bipolar Disorder (BD) and Schizophrenia (SZ). For example, methods for using such genetic markers to assess risk of developing BD and/or SZ are provided, as are methods for making a differential diagnosis between BD and SZ.
    Type: Application
    Filed: January 27, 2012
    Publication date: May 24, 2012
    Applicant: SureGene, LLC
    Inventors: Mark David Brennan, Timothy Lynn Ramsey
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE OLANZAPINE POOR RESPONSE PREDICTOR GENE SIGNATURE
    Publication number: 20120094854
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a OPRP genetic signature are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the genetic signature.
    Type: Application
    Filed: April 25, 2011
    Publication date: April 19, 2012
    Applicant: SUREGENE, LLC
    Inventors: Timothy L. Ramsey, Bharat Mehrotra, Mark D. Brennan
  • Genetic markers of schizophrenia endophenotypes
    Patent number: 8114600
    Abstract: This document provides methods and materials related to genetic markers of schizophrenia (SZ), schizotypal personality disorder (SPD), and/or schizoaffective disorder (SD), (collectively referred to herein as “schizophrenia spectrum disorders” or SSDs). For example, methods for using such genetic markers to identify an SSD (e.g., SZ) endophenotype are provided.
    Type: Grant
    Filed: November 4, 2009
    Date of Patent: February 14, 2012
    Assignee: SureGene, LLC
    Inventors: Mark David Brennan, Timothy Lynn Ramsey
  • Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
    Patent number: 7985551
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Grant
    Filed: November 4, 2009
    Date of Patent: July 26, 2011
    Assignee: Suregene, LLC
    Inventors: Timothy L. Ramsey, Mark D. Brennan
  • Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
    Patent number: 7972793
    Abstract: Methods and compositions that relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Grant
    Filed: November 3, 2010
    Date of Patent: July 5, 2011
    Assignee: Suregene, LLC
    Inventors: Timothy L. Ramsey, Mark D. Brennan
  • Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
    Patent number: 7951543
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Grant
    Filed: August 18, 2010
    Date of Patent: May 31, 2011
    Assignee: Suregene, LLC
    Inventors: Timothy L. Ramsey, Mark D. Brennan
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE SULT4A1-1 HAPLOTYPE
    Publication number: 20110105469
    Abstract: Methods and compositions that relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Application
    Filed: November 3, 2010
    Publication date: May 5, 2011
    Applicant: Suregene, LLC
    Inventors: Timothy L. Ramsey, Mark D. Brennan
  • Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature
    Patent number: 7932042
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a OPRP genetic signature are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the genetic signature.
    Type: Grant
    Filed: October 13, 2010
    Date of Patent: April 26, 2011
    Assignee: Suregene, LLC
    Inventors: Timothy L. Ramsey, Bharat Mehrotra, Mark D. Brennan
  • Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
    Patent number: 7790396
    Abstract: Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a SULT4A1-1 haplotype are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the haplotype status.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: September 7, 2010
    Assignee: Suregene, LLC
    Inventors: Timothy L. Ramsey, Mark D. Brennan
  • Genetic Markers of Schizophrenia Endophenotypes
    Publication number: 20100119625
    Abstract: This document provides methods and materials related to genetic markers of schizophrenia (SZ), schizotypal personality disorder (SPD), and/or schizoaffective disorder (SD), (collectively referred to herein as “schizophrenia spectrum disorders” or SSDs). For example, methods for using such genetic markers to identify an SSD (e.g., SZ) endophenotype are provided.
    Type: Application
    Filed: November 4, 2009
    Publication date: May 13, 2010
    Applicant: SUREGENE, LLC
    Inventors: Mark David Brennan, Timothy Lynn Ramsey
  • Genetic Markers for Assessing Risk of Developing Bipolar Disorder
    Publication number: 20100120046
    Abstract: This document provides methods and materials related to genetic markers of Bipolar Disorder (BD) and Schizophrenia (SZ). For example, methods for using such genetic markers to assess risk of developing BD and/or SZ are provided, as are methods for making a differential diagnosis between BD and SZ.
    Type: Application
    Filed: November 4, 2009
    Publication date: May 13, 2010
    Applicant: SUREGENE, LLC
    Inventors: Mark David Brennan, Timothy Lynn Ramsey